StoxGud Sign in
30

Krsnaa Diagnostics Limited

NSE: KRSNAA · Unclassified

₹475.00-1.64%06 Nov 2026

Ask the data

Instant answers about Krsnaa Diagnostics Limited — computed from its filings, no language model
Market cap₹1,541 cr
Current price₹475.00
High / Low₹827 / ₹475
P/E18.6
P/B1.48
Book value₹320.2
ROE8.0%
ROCE10.8%
Debt / equity0.57
Dividend yield0.58%
EPS (TTM)₹25.54
Face value₹5

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin
FY22FY23FY24FY25FY26
Revenue455.4487.1619.6717.2772.8
EBITDA131.5122.3144.2190.1211.9
Operating margin28.9%25.1%23.3%26.5%27.4%
Interest18.57.716.524.634.4
Depreciation41.453.874.588.390.5
Profit before tax86.580.270.0102.7130.4
Tax18.118.113.225.128.9
Net profit68.462.156.877.6101.4
EPS ₹22.8919.7817.9024.0431.30
Operating cash flow128.476.324.387.3143.1
Capex132.2141.4193.9126.6219.3
Dividend paid0.07.88.68.18.9
Total assets—909.91,171.91,281.61,823.7
Equity—738.7809.8882.8980.4

Quarterly performance

last 21 quarters · ₹ crore
showing latest 8 of 21 periods
SEP '21DEC '21MAR '22JUN '22SEP '22DEC '22MAR '23JUN '23SEP '23DEC '23MAR '24JUN '24SEP '24DEC '24MAR '25JUN '25SEP '25DEC '25MAR '26JUN '26SEP '26
Revenue108.3106.5108.2112.9122.9118.1133.2139.6155.4158.3166.3170.2186.3174.5186.1193.0206.0181.2192.6235.5271.0
Operating profit31.930.028.027.830.629.434.531.431.837.443.742.749.445.153.051.459.246.454.958.071.1
Operating margin29.5%28.2%25.9%24.6%24.9%24.9%25.9%22.5%20.5%23.6%26.3%25.1%26.5%25.8%28.5%26.6%28.7%25.6%28.5%24.6%26.2%
Other income3.24.34.14.64.34.55.94.24.24.14.37.34.69.24.44.04.23.831.57.26.2
Interest8.22.41.81.41.82.32.22.03.14.17.35.36.46.16.86.38.27.812.114.815.4
Depreciation10.310.610.412.412.913.914.615.719.521.218.121.522.222.721.921.623.622.722.627.929.1
Profit before tax16.621.419.918.720.217.823.617.913.416.122.623.225.425.528.627.431.619.851.722.432.8
Tax4.15.01.94.54.84.14.73.22.93.13.95.35.86.17.96.97.64.410.05.98.2
Net profit12.516.317.914.215.313.618.914.610.513.018.717.919.619.420.720.523.90.041.716.624.6
EPS ₹4.515.675.404.535.734.356.034.663.354.095.805.556.076.016.406.357.384.7212.865.107.64
Revenue YoY————13.6%10.9%23.1%23.7%26.4%34.1%24.8%22.0%19.9%10.2%11.9%13.4%10.5%3.8%3.5%22.0%31.5%
Profit YoY————22.4%-16.5%5.5%3.0%-31.6%-4.9%-1.0%22.4%86.7%49.7%10.4%14.5%22.2%-100.0%101.7%-19.3%2.7%

Returns & margins

trailing-twelve-month, per quarter
showing latest 8 of 18 periods
JUN '22SEP '22DEC '22MAR '23JUN '23SEP '23DEC '23MAR '24JUN '24SEP '24DEC '24MAR '25JUN '25SEP '25DEC '25MAR '26JUN '26SEP '26
ROE—9.0%8.7%8.4%8.5%7.6%7.6%7.0%7.4%8.2%9.0%8.8%9.1%9.2%7.1%8.8%8.4%8.0%
ROCE—11.4%10.9%11.4%11.4%9.5%9.5%8.9%9.8%10.5%11.5%11.7%12.2%11.6%11.3%10.9%11.1%10.8%
Net margin14.0%14.2%13.2%12.8%12.2%10.6%9.7%9.2%9.2%10.2%10.8%10.8%10.8%11.1%8.5%11.2%10.1%9.4%
EBITDA margin27.0%25.8%25.1%25.1%24.5%23.3%23.0%23.3%23.9%25.4%25.9%26.5%26.9%27.5%27.4%27.4%26.8%26.2%
Debt / equity—0.090.090.040.040.140.140.200.200.260.260.230.230.310.310.550.550.57
Interest coverage6.5611.8811.5411.4210.608.637.235.254.804.774.845.175.175.124.694.803.933.53
Asset turnover—0.490.500.540.560.510.540.530.550.530.540.560.580.500.510.420.450.43

Balance sheet

equity vs borrowings over time · ₹ crore
showing latest 6 of 9 periods
SEP '22MAR '23SEP '23MAR '24SEP '24MAR '25SEP '25MAR '26SEP '26
Share capital15.715.715.716.116.116.116.216.216.2
Other equity / reserves690.4723.0739.5793.7824.6866.6906.7964.21,022.4
Total equity706.1738.7755.2809.8840.8882.8923.0980.41,038.6
Borrowings62.632.5109.2159.8216.1203.5285.7534.3596.4
Current liabilities176.499.2240.7281.5381.1305.4407.5275.2482.2
Non-current liabilities42.272.081.680.672.793.4176.3568.1542.7
Total assets924.7909.91,077.51,171.91,294.51,281.61,506.71,823.72,063.6
Property, plant & equipment390.4467.9556.2644.7686.3667.4680.0651.6848.8
Capital work-in-progress44.125.527.79.83.53.030.2208.15.2
Investments0.30.30.30.30.331.531.657.457.4
Inventories17.325.136.435.830.729.531.526.733.3
Receivables114.273.1158.7176.3243.5277.8358.3295.5474.6
Cash & equivalents24.422.730.32.411.33.910.630.277.4

Cash flow

annual · ₹ crore · line = free cash flow
FY22FY23FY24FY25FY26
Cash from operations128.476.324.387.3143.1
Cash from investing-240.6-108.9-128.9-99.6-396.0
Cash from financing176.0-33.184.213.8279.3
Capex132.2141.4193.9126.6219.3
Free cash flow-3.8-65.1-169.5-39.3-76.2
Dividends paid0.07.88.68.18.9

Where the assets sit

Sep '26 · ₹ crore
Fixed assets (PPE)
₹848.8 cr41%
CWIP
₹5.2 cr0%
Investments
₹57.4 cr3%
Inventories
₹33.3 cr2%
Receivables
₹474.6 cr23%
Cash & equivalents
₹77.4 cr4%
Other assets
₹566.9 cr27%

Peer comparison

largest in Unclassified · this company in bold
CompanyMarket cap ₹crPriceP/EP/BROE
Avantel Limited36,86,04,549138.69—1059360.680.0%
Ducol Organics And Colours Limited19,55,275120.00—20089.130.0%
Jio Platforms Limited12,57,1811,406.40—3.57—
SBI Funds Management Limited1,01,750499.55———
Tamilnadu Telecommunication Limited91,3149.93———
Manipal Health Enterprises Limited76,294646.70———
INDO-MIM Limited59,0421,219.50———
AvenuesAI Limited45,138129.25153.69.516.2%
Dhoot Transmission Limited32,7611,601.60—8.11—
3M India Limited31,07127,570.0053.817.5732.7%
Krsnaa Diagnostics Limited1,541475.0018.61.488.0%

StoxGud checklist: Bearish setup · 3/10

  • Price above 50-day average
  • Price above 200-day average
  • 50-day average above 200-day (uptrend)
  • RSI in healthy 40–70 zone
  • Positive 1-year return
  • Return on equity above 15%
  • Debt to equity below 1
  • Revenue growing year on year
  • Net profit margin above 10%
  • P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month-13.3%
6 months-21.3%
1 year-40.0%
3Y CAGR-11.0%
5Y CAGR-7.1%
10Y CAGR—
50-day avg₹534.61
200-day avg₹577.10
RSI (14)14

FAQs

What is the share price of Krsnaa Diagnostics Limited?

Krsnaa Diagnostics Limited (KRSNAA) closed at ₹475.00 on NSE on 06 Nov 2026.

What is the market cap of Krsnaa Diagnostics Limited?

₹1,541 crore at the latest close.

What is the P/E ratio of Krsnaa Diagnostics Limited?

18.6, on trailing-twelve-month earnings from its filings.

How fast is Krsnaa Diagnostics Limited growing?

Krsnaa Diagnostics Limited: revenue has compounded at 16.6% a year over three years; net profit at 17.8% a year. Latest-quarter revenue is up 31.5% year on year, profit up 2.7%.

How profitable is Krsnaa Diagnostics Limited?

On a trailing-twelve-month basis return on equity is 8.0%, return on capital employed 10.8%, operating margin 26.2%, net margin 9.4%.

How much debt does Krsnaa Diagnostics Limited have?

Krsnaa Diagnostics Limited is moderately geared: debt to equity is 0.57 with borrowings of ₹596 cr against cash of ₹77 cr (balance sheet of 2026-09-30). Operating profit covers interest 3.5 times.

Financials parsed from Krsnaa Diagnostics Limited's own XBRL filings to NSE (consolidated), ₹ crore unless marked. Quarterly from SEP '21, annual from FY22, balance sheet from Sep '22. * = derived (full year or half year minus earlier quarters). Information only, not investment advice.